The association between ROS1 rearrangement and risk of thromboembolic events in patients with advanced non-small cell lung cancer: a multicenter study in China

BACKGROUND: According to several studies, ROS1 rearrangement is associated with thrombotic risk in non-small cell lung cancer (NSCLC). However, there is no clear understanding of the predictors and prognostic impact of thromboembolic events (TEEs) in patients with advanced ROS1 rearrangement NSCLC....

Descripción completa

Detalles Bibliográficos
Autores principales: Yi, Jiawen, Chen, Huang, Li, Jie, Jiang, Xingran, Xu, Yan, Wang, Mengzhao, Wang, Zheng, Zhai, Zhenguo, Ren, Yanhong, Zhang, Yuhui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513881/
https://www.ncbi.nlm.nih.gov/pubmed/36167545
http://dx.doi.org/10.1186/s12959-022-00417-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513881/
https://www.ncbi.nlm.nih.gov/pubmed/36167545
http://dx.doi.org/10.1186/s12959-022-00417-8

Ejemplares similares